Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Federal Trade Commission
Chinese Patent Office
Harvard Business School
Daiichi Sankyo

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201803

« Back to Dashboard

NDA 201803 describes ADVIL, which is a drug marketed by Pfizer and Pfizer Cons Hlthcare and is included in ten NDAs. It is available from four suppliers. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ADVIL profile page.

The generic ingredient in ADVIL is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.
Summary for 201803
Applicant:Pfizer Cons Hlthcare
Ingredient:ibuprofen sodium
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 201803
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Pfizer Consumer Healthcare 0573-0133 N 0573-0133-40
ADVIL ibuprofen sodium TABLET;ORAL 201803 NDA Pfizer Consumer Healthcare 0573-0133 N 0573-0133-20

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Jun 12, 2012TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.